KATIE VELTMAN: Open Payments
NPI 1114623311 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,298 in 76 payments from 16 companies in 2025. Trend: 2023 $1,145 · 2024 $5,337 · 2025 $2,298
Food & beverage: $2,298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $510 |
| Madrigal Pharmaceuticals | 7 | $358 |
| Boston Scientific Corporation | 3 | $269 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $219 |
| Janssen Biotech, Inc. | 7 | $210 |
| Ardelyx, Inc. | 5 | $194 |
| PFIZER INC. | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 5 | $51 |
| Braintree Laboratories, Inc. | 2 | $34 |
Products named: REZDIFFRA, Axonics, XIFAXAN, TREMFYA, IBSRELA, RINVOQ, ENTYVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
